Nfj Investment Group, LLC Pacira Bio Sciences, Inc. Transaction History

Nfj Investment Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $153,892 - $190,162	-6,035 Reduced 5.87%	96,847 $2.77 Million
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $375,916 - $481,499	-13,571 Reduced 11.65%	102,882 $3.01 Million
Q4 2023 Feb 15, 2024	BUY	$26.32 - $34.31 $88,935 - $115,933	3,379 Added 2.99%	116,453 $3.93 Million
Q3 2023 Nov 08, 2023	BUY	$30.68 - $40.09 $3.47 Million - $4.53 Million	113,074 New	113,074 $3.47 Million

264

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $767M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Nfj Investment Group, LLC with notifications on news.